Schroder Investment Management Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.23M | Hold |
3,608,490
| – | – | 0.01% | 673 |
|
|
2025
Q1 | $5.99M | Buy |
3,608,490
+743,858
| +26% | +$1.23M | 0.01% | 728 |
|
|
2024
Q4 | $6.33M | Hold |
2,864,632
| – | – | 0.01% | 732 |
|
|
2024
Q3 | $10.4M | Buy |
2,864,632
+412,592
| +17% | +$1.5M | 0.01% | 652 |
|
|
2024
Q2 | $8.53M | Buy |
2,452,040
+779,308
| +47% | +$2.71M | 0.01% | 663 |
|
|
2024
Q1 | $10.7M | Hold |
1,672,732
| – | – | 0.01% | 639 |
|
|
2023
Q4 | $10.8M | Hold |
1,672,732
| – | – | 0.01% | 616 |
|
|
2023
Q3 | $3.9M | Hold |
1,672,732
| – | – | 0.01% | 800 |
|
|
2023
Q2 | $3.98M | Hold |
1,672,732
| – | – | 0.01% | 828 |
|
|
2023
Q1 | $3.08M | Hold |
1,672,732
| – | – | ﹤0.01% | 872 |
|
|
2022
Q4 | $3.18M | Hold |
1,672,732
| – | – | 0.01% | 865 |
|
|
2022
Q3 | $3.58M | Hold |
1,672,732
| – | – | 0.01% | 840 |
|
|
2022
Q2 | $4.73M | Hold |
1,672,732
| – | – | 0.01% | 802 |
|
|
2022
Q1 | $7.08M | Hold |
1,672,732
| – | – | 0.01% | 755 |
|
|
2021
Q4 | $8.68M | Hold |
1,672,732
| – | – | 0.01% | 635 |
|
|
2021
Q3 | $11M | Hold |
1,672,732
| – | – | 0.02% | 612 |
|
|
2021
Q2 | $11.1M | Hold |
1,672,732
| – | – | 0.01% | 644 |
|
|
2021
Q1 | $9.59M | Hold |
1,672,732
| – | – | 0.01% | 676 |
|
|
2020
Q4 | $15M | Buy |
1,672,732
+107,082
| +7% | +$957K | 0.02% | 551 |
|
|
2020
Q3 | $17.4M | Sell |
1,565,650
-220,204
| -12% | -$2.44M | 0.03% | 463 |
|
|
2020
Q2 | $28.6M | Sell |
1,785,854
-309,273
| -15% | -$4.96M | 0.05% | 339 |
|
|
2020
Q1 | $13.3M | Hold |
2,095,127
| – | – | 0.03% | 472 |
|
|
2019
Q4 | $27.7M | Buy |
+2,095,127
| New | +$27.7M | 0.05% | 424 |
|